Inventor
BOEHM MARCUS F
US52 patents
⚠️ This page may combine multiple inventors who share the name “BOEHM MARCUS F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIGAND PHARM INC
15 patentsUS6218430B1Apr 17, 2001
Vitamin D3 mimics
LIGAND PHARM INC84 citations95
US5780676AJul 14, 1998
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
LIGAND PHARM INC81 citations95
US5998654ADec 7, 1999
Retinoic acid receptor antagonist compounds and methods
LIGAND PHARM INC21 citations93
US6083977AJul 4, 2000
Trienoic retinoid compounds and methods
LIGAND PHARM INC20 citations92
US5962731AOct 5, 1999
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
LIGAND PHARM INC30 citations92
US5721103AFeb 24, 1998
Trienoic retinoid compounds and methods
LIGAND PHARM INC35 citations92
US6545049B1Apr 8, 2003
Dimer-selective RXR modulators and methods for their use
LIGAND PHARM INC22 citations89
US6043279AMar 28, 2000
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
LIGAND PHARM INC16 citations84
US6593493B1Jul 15, 2003
RXR modulators with improved pharmacologic profile
LIGAND PHARM INC16 citations81
US6320074B1Nov 20, 2001
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
LIGAND PHARM INC18 citations81
US5514821AMay 7, 1996
Ring-labeled retinoids and intermediates, and methods for their synthesis and use
LIGAND PHARM INC10 citations74
US6610883B1Aug 26, 2003
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
LIGAND PHARM INC9 citations70
US5508456AApr 16, 1996
9-cis tritium-labeled retinoids and intermediates, methods for their synthesis and methods for their use in discovering retinoid X receptor ligands
LIGAND PHARM INC6 citations63
US7056954B2Jun 6, 2006
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
LIGAND PHARM INC3 citations62
US6992108B1Jan 31, 2006
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
LIGAND PHARM INC0 citations51
RECEPTOS INC
10 patentsUS9474755B2Oct 25, 2016
GLP-1 receptor modulators
RECEPTOS INC6 citations83
US9260427B2Feb 16, 2016
GLP-1 receptor modulators
RECEPTOS INC8 citations83
US9187522B2Nov 17, 2015
GLP-1 receptor modulators
RECEPTOS INC7 citations83
US8778923B2Jul 15, 2014
GLP-1 receptor modulators
RECEPTOS INC11 citations83
US8357706B2Jan 22, 2013
Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
RECEPTOS INC6 citations83
US9388147B2Jul 12, 2016
Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
RECEPTOS INC9 citations82
US8816121B2Aug 26, 2014
GLP-1 receptor stabilizers and modulators
RECEPTOS INC10 citations82
US8362048B2Jan 29, 2013
Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
RECEPTOS INC10 citations82
US9598430B2Mar 21, 2017
GLP-1 receptor modulators
RECEPTOS INC1 citations51
US9394264B2Jul 19, 2016
Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
RECEPTOS INC0 citations51
CONFORMA THERAPEUTICS CORP
8 patentsUS7241890B2Jul 10, 2007
Purine analogs having HSP90-inhibiting activity
CONFORMA THERAPEUTICS CORP93 citations95
US7138401B2Nov 21, 2006
2-aminopurine analogs having HSP90-inhibiting activity
CONFORMA THERAPEUTICS CORP60 citations94
US7129244B2Oct 31, 2006
Triazolopyrimidines and related analogs as HSP90-inhibitors
CONFORMA THERAPEUTICS CORP13 citations91
US7148228B2Dec 12, 2006
Pyrazolopyrimidines and related analogs as HSP90-inhibitors
CONFORMA THERAPEUTICS CORP35 citations90
US7465718B2Dec 16, 2008
Ansamycins having improved pharmacological and biological properties
CONFORMA THERAPEUTICS CORP27 citations89
US7138402B2Nov 21, 2006
Pyrrolopyrimidines and related analogs as HSP90-inhibitors
CONFORMA THERAPEUTICS CORP23 citations88
US7544672B2Jun 9, 2009
Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors
CONFORMA THERAPEUTICS CORP3 citations60
US7579462B2Aug 25, 2009
Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
CONFORMA THERAPEUTICS CORP0 citations51
SALK INST FOR BIOLOGICAL STUDI
5 patentsUS6506917B1Jan 14, 2003
Compounds and compositions useful for modulation of processes mediated by RXR
SALK INST FOR BIOLOGICAL STUDI18 citations92
US5968989AOct 19, 1999
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
SALK INST FOR BIOLOGICAL STUDI17 citations92
US5990163ANov 23, 1999
Selective modulation of processes mediated by retinoid X receptors, and compounds useful therefor
SALK INST FOR BIOLOGICAL STUDI51 citations90
US5932622AAug 3, 1999
Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid
SALK INST FOR BIOLOGICAL STUDI14 citations73
US6576676B1Jun 10, 2003
Means for the modulation of processes mediated by retinold receptors and compounds useful therefor
SALK INST FOR BIOLOGICAL STUDI4 citations62
CELGENE INT II SARL
3 patentsUS10259823B2Apr 16, 2019
GLP-1 receptor modulators
CELGENE INT II SARL7 citations83
US10239846B2Mar 26, 2019
Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
CELGENE INT II SARL2 citations71
US10034886B2Jul 31, 2018
GLP-1 receptor modulators
CELGENE INT II SARL1 citations50
CELGENE INT II SÀRL
3 patentsBOEHM MARCUS F
3 patentsEISAI INC
1 patentLILLY CO ELI
1 patentKASIBHATLA SRINIVAS RAO
1 patentShowing the top 50 of 52 patents by PatentIndex Score.